Skip to content

Can Virtual Reality Technology Improve the Patient Experience in Oocyte Retrieval?

Can Virtual Reality Technology Improve the Patient Experience in Oocyte Retrieval?

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05826938
Enrollment
82
Registered
2023-04-24
Start date
2023-03-13
Completion date
2024-03-13
Last updated
2023-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility, Female

Keywords

Infertility, Virtual reality

Brief summary

A non-pharmacological, non-blinded, randomized cohort study that will investigate the effect of Virtual Reality technology on the patient experience during oocyte retrieval. The primary objective of the trial is to investigate the impact of Virtual Reality technology on the patient experience

Interventions

Participants who are randomized to group 1 will receive the Virtual Reality glasses on the day of oocyte retrieval in the recovery room. The participant chooses which animation she wants to experience.

Sponsors

Peter Humaidan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Women undergoing oocyte retrieval * Understanding and speaking Danish

Exclusion criteria

* Previous participation in the trial * Acupuncture as pain relief during oocyte retrieval

Design outcomes

Primary

MeasureTime frameDescription
Questionnaires regarding impact on patient experience30-60 minutesThe impact of Virtual Reality technology on the patient experience during oocyte retrieval through questionnaires. A visual analog scale (VAS) from 1-10 will be used for this measurement.

Secondary

MeasureTime frameDescription
Questionnaires reagarding the impact on the consumption of analgesic medication30-60 minutesThe effect of Virtual Reality technology on the consumption of analgesic medication. A visual analog scale (VAS) from 1-10 will be used for this measurement.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026